Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-036773
Filing Date
2021-09-21
Accepted
2021-09-21 16:15:08
Documents
1
Period of Report
2021-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7044
  Complete submission text file 0000899243-21-036773.txt   8566
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Fox Allan M. (Reporting) CIK: 0001652936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37553 | Film No.: 211266639